Crossmark

Rituximab in pediatric refractory nephrotic syndrome: a systematic review and meta-analysis evaluating therapeutic efficacy and adverse event profiles

Crossref DOI link: https://doi.org/10.1007/s00467-025-07013-8

Published Online: 2025-11-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deng, Junchao

Zhu, Lizhen

Zhu, Xiaoshi
License Information

Text and Data Mining valid from 2025-11-08

Version of Record valid from 2025-11-08
More Information

Article History

Received: 20 July 2025

Revised: 28 September 2025

Accepted: 7 October 2025

First Online: 8 November 2025

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below